Publikācijas » 2010

Rezultātu skaits lapā  
Konferences
11Svalbe B.; Muceniece R.; Liepinsh E.; Dambrova M.; Zvejniece L. L-Carnitine regulator - mildronate exerts acute anticinvulsant and antihypnotic effects. Abstracts, 35th FEBS Congress Molecules of Life; June 25 - July 1: Gothenburg, Sweden. The FEBS Journal, Vol.277, Suppl. 1, A4.10, 2010; 79.      

12Zvejniece L.; Svalbe B.; Dambrova M. Antihypoxic action of an inhibitor of L-carnitine biosynthesis. Meeting of the COST Action TD0901 Oxygen in Health and Disease; June 15-18: Smolenice Castle, Slovakia, 2010; 65.      

13Kuka J.; Vilskersts R.; Vavers E.; Liepins E.; Dambrova M. Effects of regulation of L-carnitine concentration in experimental heart infarction model. Final Programme and Abstract Book, Frontiers in Cardiovascular Biology; First Congress of the European Society of Cardiology Council on Basic Cardiovascular Science; Berlin, 16-19 July: Cardiovascular Res., Vol.87, Suppl.1. Oxford Journals, 2010; 509.      

14Vilskersts R.; Kuka J.; Svalbe B.; Liepinsh E.; Dambrova M. Protective effects of L-carnitine and mildronate in salt-induced hypertension. Final Programme and Abstract Book, Frontiers in Cardiovascular Biology; First Congress of the European Society of Cardiology Council on Basic Cardiovascular Science; Berlin, 16-19 July: Cardiovascular Res., Vol.87, Suppl.1. Oxford Journals, 2010; 103.      

15Liepins E.; Skapare E.; Konrade I.; Dambrova M. The Effects of mildronate and metformin of energy metabolism pathways in experimental model of obesity. Abstract Volume 46th Annual Meeting, The European Association for the Study of Diabetes (EASD); 20-24 September: Stockholm, Sweden , 2010; 815.      

16Zviedre I.; Beļakovs S. Trimetilamonija dicitrātoborāta sintēze un kristāliskā struktūra. Programma, RTU 51. Starptautiskā Zinātniskā konference. Materiālzinātne un lietišķā ķīmija = RTU 51st International Scientific Conference. Materials Sciences and Applied Chemistry; 11.-15. oktobrī: Rīga, Latvija, 2010; 69.      

17Višņevska J.; Ābele E.; Šestakova I.; Jaščenko E.; Bridane V.; Kalviņš I. E-Hlorvinilsulfīdu un E-hlorvinilsulfonu katalitiskās pārvērtības un citotoksicitāte. Programma, RTU 51. Starptautiskā Zinātniskā konference. Materiālzinātne un lietišķā ķīmija = RTU 51st International Scientific Conference. Materials Sciences and Applied Chemistry; 11.-15. oktobrī: Rīga, Latvija, 2010; 69.      

18Stonkus V.; Leite L.; Edolfa K.; Fleišers M.; Krūmiņa A.; Rašmane Dz. Butilbutirāta ketonizācija Zn-Cr oksīdu katalizatora klātbūtnē. Programma, RTU 51. Starptautiskā Zinātniskā konference. Materiālzinātne un lietišķā ķīmija = RTU 51st International Scientific Conference. Materials Sciences and Applied Chemistry; 11.-15. oktobrī : Rīga, Latvija, 2010; 68.      

19Duburs G.; Klusa V.; Bisenieks E.; Poikans J.; Klimaviciusa L.; Pupure J. Recent progress with tauropyrone analogues. Joint Workshop Oxidative Stress and Neurodegenerative Diseases, COST Action D34 (Molecular Targeting in Drug Design in Neurological and Bacterial Diseases) and B35 (Lipid Peroxidation Associated Disorders) ; 15-17 January: Lisbon, Portugal, 2010; 22.      

20Della Corte L.; Tipton K.F.; Freinbichler W.; Weimberger P.; Bolea I.; Unzeta M.; Ballini C.; Kelly J.; Pilipenco J.; Duburs G.; Page M.; Lallemand F.; Colivicchi M.A.; Stefanini C.; Dexter D.T.; Ward R.J. Neuroprotection studies in in vitro models of neurodegeneration. COST Action D34 Final Meeting, Molecular Targeting in Drug Design for Neurological and Bacterial Diseases ; 13th-16th October: Firence, Convitto della Calza, Italy, 2010; 43.      

Rezultātu skaits lapā